Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2021-05-20 Report Publication Anno…
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Acquires One of Israel's Leading Active Medical Cannabis Trade Houses, Initiates Special Home Delivery Service in Collaboration With UPS
Report Publication Announcement Classification · 1% confidence The document is very short (1812 characters) and explicitly states, "Attached hereto is a report on*see in the attached.* *InterCure_Trade_House_final_isa.pdf*". This structure, where the filing itself is merely an announcement pointing to an attached document (likely a PDF), strongly suggests it is a notification about the publication of another report, rather than the report content itself. The filing references the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE) and is an 'Immediate Report' under Israeli regulations. Given the options, 'Report Publication Announcement' (RPA) fits best for a brief notice announcing the release of a substantive report. It is not a comprehensive report like 10-K or IR, nor is it a standard regulatory filing like RNS, as RPA is more specific for announcing the publication of reports.
2021-05-20 English
Regulatory Filings 2021
Regulatory Filings
2021-05-18 English
Announces Another Record-Breaking First Quarter Financial Results
Earnings Release Classification · 1% confidence The document is titled "InterCure Announces Another Record-Breaking First Quarter Financial Results" and provides detailed financial highlights (revenue, EBITDA, cash flow) and business highlights specifically for the "First Quarter 2021". It includes comparative tables for Q1-20 vs Q1-21 and a quarterly trend table. Crucially, it mentions that the "unaudited financial statements and accompanying notes for the periods ended March 31, 2021 and 2020 and related management's discussion and analysis of financial condition and results of operations ("MD&A") are available under the Company's profile on SEDAR". This structure—a press release summarizing quarterly results with key metrics and referencing the full financial statements/MD&A—is characteristic of an Earnings Release (ER). It is not the full comprehensive report (10-K or IR), nor is it just a management discussion (MDA) or a simple announcement of a report (RPA). Q1 2021
2021-05-18 English
Announces Another Record-Breaking First Quarter Financial Results
Report Publication Announcement Classification · 1% confidence The document is a short filing (1815 chars) submitted to the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). It explicitly states, "Attached hereto is a report on *see in the attached hereto.* *InterCure_Q1_2021_isa.pdf*". This structure—a brief announcement referencing an attached, specific report (likely a quarterly report given the 'Q1_2021' in the filename)—fits the definition of a Report Publication Announcement (RPA). It is not the full report itself, but the notice of its publication. The reference to 'Q1' suggests it relates to an Interim Report (IR), but the document's function here is purely to announce the availability of that report.
2021-05-18 English
First Quarter 2021 Financial Results
Management Reports Classification · 1% confidence The document explicitly states it is an "Interim Management's Discussion and Analysis ('MD&A') dated May 17, 2021 and provides an analysis of the financial operating results for the three months ended March 31, 2021." This content—a detailed analysis of financial results for a period shorter than a year (Q1 2021)—is the definition of an Interim/Quarterly Report. While it contains MD&A elements, the primary classification for a comprehensive interim financial report is 'IR'. It is not a short announcement (RPA) as the document is substantial (over 100k characters) and contains detailed financial tables and narrative analysis.
2021-05-18 English
First Quarter 2021 Financial Results
Report Publication Announcement Classification · 1% confidence The document is a short notification form (under 2,000 characters) submitted to the Israel Securities Authority. It explicitly states 'Attached hereto is a report on Q1 - 2021' and provides a filename 'Q12021_isa.pdf'. Per the 'MENU VS MEAL' rule, this is an announcement of a report rather than the report itself, and therefore qualifies as a Report Publication Announcement (RPA). Q1 2021
2021-05-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.